SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the LD Micro Invitational Conference. The Conference is taking place in-person at the Four Seasons in Westlake Village, CA from June 7 - 9, 2022. Details to access the presentation are as follows:Read more at globenewswire.com
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.